{
  "abstract": "Background: Exposure to elevated glucose levels during intrauterine life is detrimental to both the mother and fetus. As a glucose-sensitive organ, the placenta responds to hyperglycemia by mounting a pro-inflammatory response characterized by increased production of inflammatory mediators that disrupt the immune privilege of the maternal-fetal interface. Although hyperglycemia promotes inflammation in human placental tissue, the molecular mechanisms through which HMGB1 release and advanced glycation end products (AGEs) accumulation converge on RAGE-associated signaling pathways to sustain this response remain poorly understood.\n\nObjective: To investigate the molecular mechanisms by which hyperglycemia activates HMGB1/AGEs-dependent signaling networks leading to inflammatory responses in human placental villi.\n\nMethods: Human term placental villous explants were exposed to normal or high glucose concentrations for 1–9 h or 48 h. For pathway inhibition experiments, explants were treated with selective inhibitors during high-glucose exposure. Inflammatory mediators, extracellular HMGB1, glyoxal-derived AGEs, TLR4 and RAGE expression, and activation of Akt1, ERK1/2, and NF-κB were evaluated.\n\nResults: High-glucose exposure elicited a pro-inflammatory phenotype characterized by increased extracellular HMGB1 release, enhanced glyoxal-derived AGEs formation, and elevated TLR4 expression, supporting the involvement of HMGB1/AGE-RAGE signaling. Mechanistically, hyperglycemia was associated with activation of the PI3K/Akt and MAPK/ERK1/2 pathways, promoting NF-κB activation, suggesting the participation of both RAGE-dependent and RAGE-independent mechanisms, leading to increased secretion of TNF-α, IL-1β, and IL-6. Pharmacological inhibition experiments suggested the existence of putative interconnected positive feedback loops linking AGE accumulation, HMGB1 release, RAGE activation, and downstream inflammatory signaling, supporting the establishment of a self-sustaining metainflammatory network in placental villi.\n\nConclusions: Collectively, these findings provide insight into the mechanisms by which sustained maternal hyperglycemia reshapes placental immune signaling and promotes a chronic metainflammatory state that may compromise placental function. Our results support a mechanistic model in which HMGB1/AGE-RAGE/TLR4 signaling contributes to placental dysfunction during gestational hyperglycemia.\n\nSupplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s10020-026-01604-3.",
  "abstract_shown": true,
  "affiliations": [
    "Departamento de Inmunobioquímica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico",
    "Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City, Mexico",
    "Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico",
    "Unidad de Investigación Médica en Medicina Reproductiva, UMAE, Hospital de Gineco-Obstetricia no. 4 “Luis Castelazo Ayala”, Instituto Mexicano del Seguro Social, Mexico City, Mexico",
    "SECIHTI- Hospital Infantil de México Federico Gómez, Mexico City, Mexico",
    "Subdirección de Investigación Biomédica, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico",
    "Departamento de Ginecología y Obstetricia, Hospital Ángeles México, Mexico City, Mexico",
    "Ginecología y Obstetricia, Hospital Ángeles Lomas – UNAM, Huixquilucan, Mexico",
    "Dirección de Investigación, Instituto Nacional de Perinatología Isidro Espinosa de los Reyes, Mexico City, Mexico"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 16,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Donovan Vargas-Alcantar"
    },
    {
      "affs": [
        0
      ],
      "name": "Karina Martínez-Garfias"
    },
    {
      "affs": [
        0
      ],
      "name": "Karla Hernández-Bones"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Rodrigo Jiménez-Escutia"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Samara Rodríguez-Flores"
    },
    {
      "affs": [
        2
      ],
      "name": "Eulises Díaz-Díaz"
    },
    {
      "affs": [
        3
      ],
      "name": "Aleida Olivares"
    },
    {
      "affs": [
        4
      ],
      "name": "Lourdes Alvarez-Arellano"
    },
    {
      "affs": [
        2
      ],
      "name": "Consuelo Lomas-Soria"
    },
    {
      "affs": [
        5
      ],
      "name": "Ismael Mancilla-Herrera"
    },
    {
      "affs": [
        6
      ],
      "name": "Pilar Velázquez-Sánchez"
    },
    {
      "affs": [
        7
      ],
      "name": "Rodrigo Zamora-Escudero"
    },
    {
      "affs": [
        7
      ],
      "name": "Paloma Cervantes-Delgado"
    },
    {
      "affs": [
        2
      ],
      "name": "Lorenza Díaz"
    },
    {
      "affs": [
        8
      ],
      "name": "Verónica Zaga-Clavellina"
    },
    {
      "affs": [
        0
      ],
      "name": "Andrea Olmos-Ortiz"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/e6pvkt5v05xgy.bib",
  "cited_by": 0,
  "doi": "10.1186/s10020-026-01604-3",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13746405/",
  "id": "e6pvkt5v05xgy",
  "issns": [
    "1076-1551",
    "1528-3658"
  ],
  "landing_url": "https://doi.org/10.1186/s10020-026-01604-3",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Research"
    ],
    [
      "lcc",
      "QD415-436"
    ],
    [
      "lcc",
      "RM1-950"
    ],
    [
      "openalex",
      "1308|Advanced Glycation End Products research"
    ]
  ],
  "openalex": "W7202265031",
  "pdf_url": null,
  "pmcid": "PMC13746405",
  "pmid": "43004165",
  "published": "2026-08-01",
  "publisher": "The Feinstein Institute for Medical Research",
  "ris": "https://research.draconitic.com/paper/e6pvkt5v05xgy.ris",
  "sources": [
    {
      "first_seen": "2026-11-11T12:23:45Z",
      "native_id": "PMC13746405",
      "source": "pmc",
      "url": "https://doi.org/10.1186/s10020-026-01604-3"
    },
    {
      "first_seen": "2026-11-15T15:21:03Z",
      "native_id": "025bb50a6a4847d8b102c87305c9092b",
      "source": "doaj",
      "url": "https://doi.org/10.1186/s10020-026-01604-3"
    }
  ],
  "subjects": [
    {
      "field": "biochemistry",
      "origin": "lcc:QD415-436",
      "subfield": "general"
    },
    {
      "field": "medicine",
      "origin": "lcc:RM1-950",
      "subfield": "pharmacology-toxicology"
    }
  ],
  "title": "Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways",
  "title_text": "Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T15:20:59Z",
  "url": "https://research.draconitic.com/paper/e6pvkt5v05xgy",
  "venue": "Molecular Medicine",
  "versions": []
}